Dr. Steven Michael Rosenthal, MD

Dr. Rosenthal practices at Barbourville ARH Hospital in Barbourville, Kentucky.

Dr. Rosenthal's NPI, 1952300279, was assigned on July 19, 2005. Dr. Rosenthal graduated from McGill University, Faculty of Medicine in 1980. Dr. Rosenthal holds Georgia license 036445.

Dr. Rosenthal's primary practice is Barbourville ARH Hospital, at 80 Hospital Dr, Barbourville, KY 40906 in Knox County. The practice phone is (606) 545-5500.

Dr. Rosenthal's primary practice is Barbourville ARH Hospital in Barbourville, Kentucky. Dr. Rosenthal is also affiliated with AdventHealth Manchester. The medical group on file is AdventHealth Manchester. Dmand AI also links Dr. Rosenthal to 3 more medical groups and 2 rural health clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosenthal practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Rosenthal's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Rosenthal is licensed in Georgia.

CMS data shows 120 Medicare services from Dr. Rosenthal across 3 procedure codes in 2024, for 94 Medicare patients. Medicare paid $3,356 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 94 Medicare patients who saw Dr. Rosenthal in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 50% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rosenthal's median patient age at 68, with 54% women.

In 2024, Dr. Rosenthal wrote 1,596 Medicare Part D claims for 207 patients. 66% of them were for generic drugs. CMS names the drug for 1,441 of them, across 25 drugs with 11 or more claims each, at $562,406 in total drug cost. In 2023, CMS named 1,396 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Rosenthal for performance year 2024, reported as part of a group. Dr. Rosenthal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 49 general payments to Dr. Rosenthal from 19 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $366.

Dr. Rosenthal graduated from McGill University, Faculty of Medicine in 1980.